FoxO3a Reduces Tamoxifen Resistant Breast Cancer Aggressiveness by Inducing Integrin a5 Expression

被引：0
|
作者：
Ricci, Elena
Fava, Mariarosa
Rizza, Pietro
Pellegrino, Michele
Sisci, Diego
Morelli, Catia
机构：
来源：
FASEB JOURNAL | 2021年 / 35卷
关键词：
D O I：
10.1096/fasebj.2021.35.S1.05333
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression
    Ricci, Elena
    Fava, Mariarosa
    Rizza, Pietro
    Pellegrino, Michele
    Bonofiglio, Daniela
    Casaburi, Ivan
    Lanzino, Marilena
    Giordano, Cinzia
    Bruno, Rosalinda
    Sirianni, Rosa
    Barone, Ines
    Sisci, Diego
    Morelli, Catia
    CANCERS, 2022, 14 (01)
  • [2] FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity
    Fiorillo, Marco
    Ricci, Elena
    Fava, Mariarosa
    Longobucco, Camilla
    Sotgia, Federica
    Rizza, Pietro
    Lanzino, Marilena
    Bonofiglio, Daniela
    Conforti, Francesca Luisa
    Catalano, Stefania
    Barone, Ines
    Morelli, Catia
    Aquila, Saveria
    Lisanti, Michael P.
    Sisci, Diego
    CELLS, 2023, 12 (24)
  • [3] Study of FOXO3a and the development of tamoxifen resistance in breast cancer
    Chen, Jie
    Wu, Lai-han
    Ip, Ying-Chi
    Chan, Kelvin Y. K.
    Lam, Eric W-F
    Khoo, Ui-soon
    CANCER RESEARCH, 2009, 69
  • [4] FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
    Pellegrino, Michele
    Rizza, Pietro
    Dona, Ada
    Nigro, Alessandra
    Ricci, Elena
    Fiorillo, Marco
    Perrotta, Ida
    Lanzino, Marilena
    Giordano, Cinzia
    Bonofiglio, Daniela
    Bruno, Rosalinda
    Sotgia, Federica
    Lisanti, Michael P.
    Sisci, Diego
    Morelli, Catia
    CANCERS, 2019, 11 (12)
  • [5] Foxo3a Expression Is a Prognostic Marker in Breast Cancer
    Jiang, Ying
    Zou, Lin
    Lu, Wei-Qi
    Zhang, Yong
    Shen, Ai-Guo
    PLOS ONE, 2013, 8 (08):
  • [6] Survivin and Foxo3a Expression - Implications for Chemoresistance in Breast Cancer Cells
    Nestal de Moraes, G.
    Cunha Vasconcelos, F.
    Delbue, D.
    Lani Silva, K.
    Mognol, G.
    Viola, J.
    Maia, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S182 - S183
  • [7] FOXO3a expression in colorectal cancer: A promising biomarker of micrometastases
    Bruce, A.
    Bullock, M.
    Curtis, N.
    Sreekumar, R.
    Primrose, J.
    Thomas, G.
    Mirnezami, A. H.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 7 - 7
  • [8] Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
    McGovern, Ursula B.
    Francis, Richard E.
    Peck, Barrie
    Guest, Stephanie K.
    Wang, Jun
    Myatt, Stephen S.
    Krol, Janna
    Kwok, Jimmy M-M.
    Polychronis, Andreas
    Coombes, R. Charles
    Lam, Eric W-F.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (03) : 582 - 591
  • [9] Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
    Song, Ying
    Lu, Minying
    Qiu, Huisi
    Yin, Jiang
    Luo, Kai
    Zhang, Zhijie
    Jia, Xiaoting
    Zheng, Guopei
    Liu, Hao
    He, Zhimin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (01) : 57 - 62
  • [10] Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review
    Taylor, Simon
    Lam, Matthew
    Pararasa, Chathyan
    Brown, James E. P.
    Carmichael, Amtul R.
    Griffiths, Helen R.
    CANCER CELL INTERNATIONAL, 2015, 15
12345